You have been referred to the osteoporosis clinic because you have sustained a fracture of the *hip / vertebra / wrist.

Similar documents
Dumfries and Galloway. Treatment Protocol for Osteoporosis

Osteoporosis Clinical Guideline. Rheumatology January 2017

Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Understanding NICE guidance. NICE technology appraisal guidance advises on when and how drugs and other treatments should be used in the NHS.

Pathway from Fracture or Risk Factor to Treatment

Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women

Fracture Liaison Service and nhfd Local provision in London

Osteoporosis challenges

DENOSUMAB SHARED CARE GUIDLINES

Horizon Scanning Technology Briefing. Zoledronic Acid (Aclasta) once yearly treatment for postmenopausal. National Horizon Scanning Centre

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness

Case Finding and Risk Assessment for Osteoporosis

Initial Pathway for DEXA Referral and Treatment for Fracture Risk Reduction in Postmenopausal Women and Men Age 50 or Above

Audit on follow-up of patients with primary Osteoporosis

Denosumab for the treatment of osteoporosis in postmenopausal women at increased risk of fractures

Denosumab (Prolia 60 mg) Effective Shared Care Agreement For the treatment of Osteoporosis. Date: Date:

Quality and Outcomes Framework Programme NICE cost impact statement July Indicator area: Osteoporosis - fragility fracture

S H A R E D C A R E G U I D E L I N E Drug: Denosumab 60mg injection Indication: treatment of osteoporosis in postmenopausal women

Bone Density Measurement in Women

Aromatase Inhibitors & Osteoporosis

Summary. Background. Diagnosis

Clinical Specialist Statement Template

John J. Wolf, DO Family Medicine

FRiSCy Oxford Fracture Prevention Service

Autonomic neuropathy

Barts Health NHS Trust and local GPs Shared Care Guidelines. DENOSUMAB (Prolia) Post menopausal osteoporosis

An audit of osteoporotic patients in an Australian general practice

SCHEDULE 2 THE SERVICES. A. Service Specifications

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE SHARED CARE AGREEMENT

Page 1

Bone density scanning and osteoporosis

[If no, skip to question 10.] Y N. 2. Does the member have a diagnosis of Paget s disease of bone? Y N. [If no, skip to question 4.

3. Has bone specific alkaline phosphatase level increased OR does the member have symptoms related to active Paget s?

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

1

Osteoporosis. Treatment of a Silently Developing Disease

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

Drug Intervals (Holidays) with Oral Bisphosphonates

Strong bones after 50 Fracture liaison services explained A guide for patients, carers and families

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and social care directorate Quality standards and indicators Briefing paper

Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

New 2010 Osteoporosis Guidelines: What you and your health provider need to know QUESTIONS&ANSWERS

Strong bones after 50 Fracture liaison services explained A guide for patients, carers and families

APPLICATION FOR PODIATRY ASSESSMENT

Using the FRAX Tool. Osteoporosis Definition

Administration of Denosumab (PROLIA ) for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures

HIV and your Bones Osteopenia and Osteoporosis

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464

Osteoporosis/Fracture Prevention

Prevention of Osteoporotic Hip Fracture

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) OSTEOPOROSIS GUIDELINE

Bone Densitometry. What is a Bone Density Scan (DXA)? What are some common uses of the procedure?

Issue date: October Review date: July 2010

Osteoporosis as a Focus for Practice Improvement

EU Osteoporosis Report SWEDEN

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

Skeletal Manifestations

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

BEST PRACTICE FRAMEWORK QUESTIONNAIRE

Guidelines on Management of Osteoporosis

Osteoporosis: Who, What, When, Why, and How

All about. Osteoporosis

Technology appraisal guidance Published: 9 August 2017 nice.org.uk/guidance/ta464

Practical Management Of Osteoporosis

Osteoporosis Update. Greg Summers Consultant Rheumatologist

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

Osteoporosis. Osteoporosis ADD PICTURE

Summary of the risk management plan by product

WAHT- TWI Guidelines for Osteoporosis in Worcestershire.

Osteoporosis update. Dr. Claire Vandevelde Consultant Rheumatologist, LTHT

My joints ache. What is the difference between osteoporosis and osteoarthritis?

Bone health. Kirstie Stenhouse, NHS Forth #ACFALLS2018 #SPSP10

Review of bisphosphonate prescribing May 2014

The Glasgow UK Experiment: What a Working System Can Deliver

Bone Densitometry Pathway

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

Building Bone Density-Research Issues

Essential Shared Care Agreement Naltrexone

DEXA SCAN POLICY CRITERIA BASED ACCESS

Adjuvant bisphosphonate

Dartmouth General Hospital Fracture Liaison Service. Carla Purcell BScN, RN, CMSN(C) Fracture Navigator

Technology appraisal guidance Published: 27 October 2008 nice.org.uk/guidance/ta160

BONIVA (ibandronate sodium)

Liothyronine for treatment resistant depression

Name of Shared Care Agreement: AZATHIOPRINE/6-MERCAPTOPURINE: Oral immunomodulating drugs for inflammatory bowel disease. Reference number: 01/2008

Developed by Marion Wood and Children s Dental Needs Steering Group

Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS.

Western Locality Shared care Information ~ Penicillamine, Rheumatology April 2013

Osteoporosis. Overview

Talking to patients with osteoporosis about initiating therapy

Oxford University Hospitals Guidelines for Adjuvant Bisphosphonate treatment for Post-Menopausal Women with Early Breast Cancer

FRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

May Professor Matt Stevenson School of Health and Related Research, University of Sheffield

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

Make your. first break. your last.

Osteoporosis. World Health Organisation

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Transcription:

EXAMPLE 1a FRACTURE PATIENT INVITE LETTER «ClinicPhone» «PatientAddress1» «PatientAddress2» «PatientAddress3» «PatientAddress4» «PatientPostcode» Dear «PatientTitle» «PatientSurname» You have been referred to the osteoporosis clinic because you have sustained a fracture of the *hip / vertebra / wrist. This indicates that your bones are thin and that you may have osteoporosis. This puts you at risk of having another fracture. Further investigations are required and treatment may be indicated to reduce the risk of another fracture. Please make a routine appointment to be seen in the osteoporosis clinic by calling the above number. We have enclosed a form to have blood tests done. Please come to the Phlebotomy Dept (level 2, orange wing) with the form to have the tests done at least 2 weeks before your appointment. Phlebotomy is open Mon Fri 8.30am 4 pm If you do not make an appointment we assume you do not want further treatment. Osteoporosis Specialist Nurse

EXAMPLE 1b PATIENT INVITE LETTER «PatientAddress1» «PatientAddress2» «PatientAddress3» «PatientAddress4» «PatientPostcode» Dear «PatientTitle» «PatientSurname» «openingpara» An appointment has been made for you on at «closingpara» «comment» Osteoporosis Specialist Nurse

EXAMPLE 2a GP PATIENT LETTER Secondary Prevention Risk Factor Osteoporosis Clinic Another Hospital Uxbridge Road Southall 000 000 Dr EJ SMITH THE SURGERY ANOTHER ROAD CHANDLERS FORD EASTLEIGH HAMPSHIRE 000 000 Dear Dr SMITH, Mrs Belinda TEST Dob: 27/11/1955 Hospital Ref: 123 Your patient has attended Hospital following a fracture of the hip. This indicates that the patient probably has osteoporosis and is at risk of further fracture. As the patient is over 75 no DXA scan is required. We would suggest screening for secondary causes of osteoporosis by carrying out FBC, and serum creatinine, liver function tests, calcium, vitamin D, CRP and immunoglobulin electrophoresis (to exclude paraprotein.) NICE guidelines for the secondary prevention of osteoporotic fragility fracture were published in 2005. These recommend treatment with bisphosphonates for patients over 75 who have sustained a fragility fracture. We would recommend starting risedronate 35mg weekly (or alendronate 70mg weekly) providing there are no contraindications to bisphosphonates (eg dysphagia, history of oesophageal ulcer, severe renal impairment, patient unable to comply with bisphosphonate instructions) plus calcium and vitamin D supplements (eg Calcichew D3 forte 1 bd.) If bisphosphonates are contra-indicated or poorly tolerated we would suggest prescribing strontium ranelate 2g nocte, again with calcium supplements. We have written to the patient suggesting that they make an appointment to discuss this with you If there are any problems with this, or you would prefer the patient to be seen in the osteoporosis clinic please do not hesitate to contact us., Consultant Rheumatologist CC: Mrs Belinda TEST

EXAMPLE 2B GP PATIENT INVITE LETTER Ref: NHS Ref: «PatientNHSRef» «GPTitle» «GPInitial» «GPSurname» «GPAddress1» «GPAddress2» «GPAddress3» «GPAddress4» «GPPostcode» Dear «GPTitle» «GPSurname», «PatientDoB» «PatientGender» Hospital Ref: «PatientHospitalRef» Your patient has been invited to attend the Osteoporosis Service for an assessment on I will be writing to inform you of his progress. Day Services Manger

EXAMPLE 2C GP LETTER PT REFUSAL Ref: NHS Ref: «PatientNHSRef» «GPTitle» «GPInitial» «GPSurname» «GPAddress1» «GPAddress2» «GPAddress3» «GPAddress4» «GPPostcode» Dear «GPTitle» «GPSurname», «PatientDoB» «PatientGender» Hospital Ref: «PatientHospitalRef» Your patient has been invited to attend the Osteoporosis Service for an assessment, but has refused this invitation. We will not be offering a further appointment unless you specifically request this. Day Services Manger

EXAMPLE 2D GP PATIENT DNA LETTER Ref: NHS Ref: «PatientNHSRef» «GPTitle» «GPInitial» «GPSurname» «GPAddress1» «GPAddress2» «GPAddress3» «GPAddress4» «GPPostcode» Dear «GPTitle» «GPSurname», «PatientDoB» «PatientGender» Hospital Ref: «PatientHospitalRef» Your patient who was referred to the Osteoporosis Clinic did not attend the appointment on.. A new appointment will not be made but I will accept another referral if it is considered appropriate. Osteoporosis Specialist Nurse

EXAMPLE 3 GP/HEALTH PROFESSIONAL INAPPROPRIATE REFERRAL LETTER «ClinicPhone» «ClinicFax» Ref: NHS Ref: «PatientNHSRef» «GPor health professional Title» «GPInitial» «GPSurname» «GPor health professional Address1» «GPor health professional Address2» «GPor health professional Address3» «GPor health professional Address4» «GPor health professional Postcode» Dear «GPor health professional Title» «Surname», «PatientDoB» «PatientGender» Hospital Ref: «PatientHospitalRef» Thank you for referring your patient to the Osteoporosis Service. On reviewing their details we have decided that this referral is inappropriate for the service that we provide. It is felt that the patient would be better seen by Day Services Manager

EXAMPLE 4 DEXA REQUEST ANY Hospitals NHS Trust PARK HOSPITAL MEDICAL PHYSICS DEPARTMENT BONE DENSITOMETRY REQUEST (DEXA) Fax: 000 000 000 Tel: 000 000 000 ZYF 113 Consultant/GP «GPTitle» «GPInitial» «GPSurname» Hospital: Bleep No. nvestigation Required DEXA GP ADDRESS (If GP Referral) «GPTitle» «GPInitial» «GPSurname» «GPAddress1» «GPAddress2» «GPAddress3» «GPAddress4» «GPPostcode» P.C.G. Name: ANONYMOUS Date of Birth «PatientDoB» Title «PatientTitle» Address: «PatientAddress1» «PatientAddress2» «PatientAddress3» «PatientPostcode» Tel: «PatientPhone» Surname «PatientSurname» Hospital Number First Name «PatientFirstname» Doctor s Signature Date of Referral Ward/Dept NHS/PP Please tick relevant boxes Repeat Bone Density Scan Family History of Osteoporosis Fracture History Radiographic Evidence Loss of Height Kyphosis Early Menopause Hysterectomy Oophorectomy Clinical Information Corticosteroid Therapy Immobility History of smoking Alcohol Consumption Vegetarian Diet Anorexia Nervosa Competitive Sport Training Primary Hypogonadism Endocrine Condition Date of Next Clinic Appointment Additional Clinical Information Peripheral Scan T-Score: Medical Physics Use Only Test justified/authorised by: Ht Wt Appointment Time Appointment Time

EXAMPLE 5 GP DISCHARGE LETTER «ClinicPhone» «ClinicFax» Ref: NHS Ref: «PatientNHSRef» «GPTitle» «GPInitial» «GPSurname» «GPCode» «GPAddress1» «GPAddress2» «GPAddress3» «GPAddress4» «GPPostcode» «GPPhone» Dear «GPTitle» «GPInitial» «GPSurname», «PatientDoB» «PatientGender» Hospital Ref: «PatientHospitalRef» Your patient who has currently been attending the Osteoporosis Clinic and will be discharged on A follow up has/has not been arranged. Kind regards. Day Services Manager

EXAMPLE 6 GP RESULTS LETTER showing suggested content for use in an Osteoporosis clinic. Please add to/delete/edit the suggestions to your own requirements, you may have as many choices in each section as you wish. The sentences will appear in drop down boxes from which you choose those relevant to each patient. Osteoporosis 113A Winchester Road Chandlers Ford Eastleigh Hampshire SO53 2GH Phone not available. Ref: NHS Ref: 123 Dr EJ BOVETT G0232126 THE BROWNHILL SURGERY 2 BROWNHILL ROAD CHANDLERS FORD EASTLEIGH HAMPSHIRE SO53 2ZB Dear Dr EJ BOVETT, Mrs Belinda TEST DOB 27/11/1955 113 Winchester Road, Chandlers Ford, Eastleigh, -, SO51 1GY Hospital Ref: 123 Opening para Example 1: Thank you for referring this patient to the osteoporosis service, the results of their assessment and our recommendation are outlined below. Opening para Example 2: This patient has been assessed in the osteoporosis clinic the, results of their assessment together with my recommendations for their management are outlined below. Opening para Example 3: Thank you for referring this patient to the osteoporosis clinic Please contact me if you have any further concerns about this patient. BMD Scores Date Site Score T Score Z Score Machine 08/03/2006 Wrist 8-2.5-2.5 PIXI Interpretation: This patient's BMD at the spine is normal This patient's BMD at the spine is Osteopaenic This patient's BMD at the spine is Osteoporotic This patient's BMD at the spine is severely Osteoporotic This patient's BMD at the hip is normal This patient's BMD at the hip is Osteopaenic This patient's BMD at the hip is Osteoporotic This patient's BMD at the hip is severely Osteoporotic The result indicated that this patient is at increased fracture risk The result indicated that this patient is at increased falls risk. Vertebral morphormetry suggest a fracture of the vertebra. Vertebral morphormetry suggest multiple fractures of the vertebra. Risk Factors /Issues Identified:

Post surgical menopause Early Menopause Steroid Usage Height Loss Low Trauma Fracture Low Body Mass Index Frequent faller Recurrent back pain Maternal history of hip fracture Celiac disease Rheumatoid arthritis Recommendation: Please consider a bisphosphonate for treating this patient Please consider a bisphosphonate with calcium and vitamin D for treating this patient Please consider alendronate 70mgs weekly for treating this patient I have commenced this patient on alendronate 70mgs weekly I have commenced this patient on calcium and vitamin D tablets daily This patient has been referred to the falls services This patient has been referred to the physiotherapist I have referred this patient for a BMD measurement I have referred this patient to the home hazard team. I have referred this patient to The Stop Smoking Clinic Closing para Example 1: Please contact me if you need any further help managing this patient. Closing para Example 2: If you have any problems with the management of this patient, please don't hesitate to contact me. Comments example: This where you can add free text Consultant Rheumatologist CC: Mrs Belinda TEST